Subscribe
Preliminary phase 1 data showed that RSV neutralizing antibodies for non-adjuvanted SCB-1019 matched GSK’s AS01E-adjuvanted RSV vaccine, Arexvy.
ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals
Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults
IDWeek 2024: Novavax Reports Positive Data for Novel Influenza and Flu-COVID-19 Combination Vaccines
New Data Highlight Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake
Solange Peters, MD, PhD; Myung-Ju Ahn, MD, PhD; Luis Paz-Ares, MD, PhD; Jacob Sands, MD
Solange Peters, MD, PhD; Stephanie McDonald, FNP-BC, AOCNP; Antonio Passaro, MD, PhD; Jacob Sands, MD
Krish Patel, MD; Girish Kunapareddy, MD
Kamel Abou Hussein, MD
Jonathan Goldman, MD; Erminia Massarelli, MD, PhD, MS; Jorge J. Nieva, MD; Ignacio I. Wistuba, MD
Krish Patel, MD; Tara Graff, DO, MS